The impact of cannabis and stimulant disorders on diagnostic stability in psychosis

Journal of Clinical Psychiatry

Volumn 75, Issue 4, 2014, Pages 349-356

  Sara, Grant E ^a,b,d   Burgess, Philip M ^d   Malhi, Gin S ^b,c   Whiteford, Harvey A ^d   Hall, Wayne C ^e  

^a New South Wales   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c ROYAL NORTH SHORE HOSPITAL   (Australia)

^d UNIVERSITY OF QUEENSLAND   (Australia)

^e UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; CANNABIS; CENTRAL STIMULANT AGENT;

ADULT; AFFECTIVE PSYCHOSIS; ALCOHOL ABUSE; ARTICLE; CANNABIS ADDICTION; COMORBIDITY; DIAGNOSTIC VALUE; DISEASE COURSE; FEMALE; HUMAN; ICD-10; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCHIZOPHRENIA; SUBSTANCE ABUSE;

ADOLESCENT; ADULT; FEMALE; HUMANS; MALE; MARIJUANA ABUSE; MIDDLE AGED; PSYCHOTIC DISORDERS; RETROSPECTIVE STUDIES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SUBSTANCE-RELATED DISORDERS; YOUNG ADULT;

EID: 84899737898     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/jcp.13m08878     Document Type: Article

References (35)

1. Bromet EJ, Kotov R, Fochtmann U, et al. Diagnostic shifts during the decade following first admission for psychosis. Am I Psychiatry. 2011;168(11):1186-1194.
2. Haahr U, Friis S, Larsen TK, et al. First episode psychosis: Diagnostic stability over one and two years. Psychopathology. 2008;41(5):322-329.
3. Crebbin K, Mitford E, Paxton R, et al. First episode drug induced psychosis: A medium term follow up study reveals a high risk group. Soc Psychiatry PsychiatrEpidemiol. 2009;44(9):710-715.
4. Whitty P, Clarke M, McTigue 0, et al. Diagnostic stability four years after a first episode of psychosis. Psychiatr Serv. 2005;56(9):1084-1088.
5. Addington J, Addington D. Patterns, predictors and impact of substance use in early psychosis: A longitudinal study. Acta Psychiatr Scand. 2007;115(4):304-309.
6. Wade D, Harrigan S, Edwards J, et al. Patterns and predictors of substance use disorders and daily tobacco use in first episode psychosis. Aust N Z I Psychiatry. 2005;39(10):892-898.
7. Kavanagh DJ, Waghorn G, Jenner L, et al. Demographic and clinical correlates of comorbid substance use disorders in psychosis: Multivariate analyses from an epidemiological sample. SchizophrRes. 2004;66(2-3):115-124.
8. Moore E, Mancuso SG, Slade T, et al. The impact of alcohol and illicit drugs on people with psychosis: The second Australian National Survey of Psychosis. AustNzfPsychiatry. 2012;46(9):864-878.
9. Regier DA, Farmer ME, Rae DS, et al. Comorbidity of mental disorders with alcohol and other drug abuse: Results from the Epidemiologic Catchment Area (ECA) Study. JAMA. 1990;264(19):2511-2518.
10. Mathias S, Lubman DI, Hides L. Substance induced psychosis: A diagnostic conundrum. I Clin Psychiatry. 2008;69(3):358-367.
11. Gonzalez Pinto A, Alberich S, Barbeito S, et al. Cannabis and first episode psychosis: Different long term outcomes depending on continued or discontinued use. Schizophr Bull. 201-1;37(3):63-1 639.
12. Wade D, Harrigan S, Edwards J, et al. Substance misuse in first episode psychosis: 15 month prospective follow up study. BrJPsychiatry. 2006;189(3):229-234.
13. Wade D, Harrigan S, McGorry PD, et al. Impact of severity of substance use disorder on symptomatic and functional outcome in young individuals with first episode psychosis. I Clin Psychiatry. 2007;68(5):767-774.
14. Sorbara F, Liraud F, Assens F, et al. Substance use and the course of early psychosis: A 2 year follow up of first admitted subjects. Eur Psychiatry. 2003;18(3):133-136.
15. Bertelsen M, Jeppesen P, Petersen L, et al. Course of illness in a sample of 265 patients with first episode psychosis five year follow up of the Danish OPUS trial. SchizophrRes. 2009;107(2-3):173-178.
16. Malla A, Norman R, Bechard Evans L, et al. Factors influencing relapse during a 2 year follow up of first episode psychosis in a specialized early intervention service. Psychol Med. 2008;38(1-1): 1585-1593.
17. Schwartz JE, Fennig S, Tanenberg Karant M, et al. Congruence of diagnoses 2 years after a first admission diagnosis of psychosis. Arch Gen Psychiatry. 2000;57(6):593-600.
18. Naz B, Bromet EJ, Mojtabai R. Distinguishing between first admission schizophreniform disorder and schizophrenia. SchizophrRes. 2003;62(1-2):51
19. Hall N, Degenhardt L. Cannabis and the increased incidence and persistence of psychosis. BMJ. 201-1;342:d719.
20. Sara G, Burgess P, Malhi GS, et al. Differences in associations between cannabis and stimulant disorders in first admission psychosis. Schizophr Res. 2013;147(2-3):216-222.
21. Hides L, Dawe S, Kavanagh DJ, et al. Psychotic symptom and cannabis relapse in recent onset psychosis: Prospective study. BrfPsychiatry. 2006;189(2):137-143.
22. Angrist B, Corwin J, Bartlik B, et al. Early pharmacokinetics and clinical effects of oral D amphetamine in normal subjects. Biol Psychiatry. 1987;22(11):1357-1368.
23. Hermens DF, Lubman DI, Ward PB, et al. Amphetamine psychosis: A model for studying the onset and course of psychosis. MedJ Aust. 2009;190(suppl):S22 S25.
24. Curran C, Byrappa N, McBride A. Stimulant psychosis: Systematic review. Br JPsychiatry. 2004;185(3):196-204.
25. Keshavan MS, Tandon R, Boutros NN, et al. Schizophrenia, "just the facts": What we know in 2008 part 3: Neurobiology. Schizophr Res. 2008;106(2-3):89-107.
26. Laruelle M, Abi Dargham A. Dopamine as the wind of the psychotic fire: New evidence from brain imaging studies. JPsychopharmacol. 1999;13(4):358-371.
27. Niemi Pyntt?ri JA, Sund R, Putkonen H, et al. Substance induced psychoses converting into schizophrenia: A register based study of 18,478 Finnish inpatient cases. I Clin Psychiatry. 2013;74(1):e94 e99.
28. National Centre for Classification in Health. The International Statistical Classification of Diseases and Related Health Problems, Tenth Revision, Australian ModUication. 7th ed. Sydney, Australia: National Centre for Classification in Health, Faculty of Health Sciences, The University of Sydney; 2010.
29. Belsley D. A guide to using the collinearity diagnostics. Comput Sci Econ Managet. 1991;4:33
30. Arendt M, Rosenberg R, Foldager L, et al. Cannabis induced psychosis and subsequent schizophrenia spectrum disorders: Follow up study of 535 incident cases. BrfPsychiatry. 2005;187(6):510-515.
31. Castagnini A, Bertelsen A, Berrios GE. Incidence and diagnostic stability of ID 10 acute and transient psychotic disorders. Compr Psychiatry. 2008;49(3):255-261.
32. Baca Garcia E, Perez Rodriguez MM, Basurte Vilamor I, et al. Diagnostic stability of psychiatric disorders in clinical practice. BrJPsychiatry. 2007;190(3):210-216.
33. Bromet EJ, Naz B, Fochtmann U, et al. Long term diagnostic stability and outcome in recent first episode cohort studies of schizophrenia. Schizophr Bull. 2005;31(3):639-649.
34. Large MM, Smith GS, Sara G, et al. Meta analysis of self reported substance use compared with laboratory substance assay in general adult mental health settings. IntJ Methods Psychiatr Res. 2012;21 (2): 134-148.
35. Morgan VA, Jablensky AM From inventory to benchmark: Quality of psychiatric case registers in research. BrJPsychiatry. 2010;197(1):8-10.